Lucyd Stock (NASDAQ:LUCY)

Revenue Ownership Financials Chart

Previous Close

$0.72

52W Range

$0.65 - $2.24

50D Avg

$0.81

200D Avg

$1.12

Market Cap

$4.29M

Avg Vol (3M)

$4.46M

Beta

2.71

Div Yield

LUCY Company Profile

Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names. The company also provides Lucyd app for unlimited ChatGPT interactions and tech support. It sells its products through e-commerce and a network of retail stores of resellers. The company was formerly known as Innovative Eyewear, Inc. and changed its name to Lucyd, Inc in October 2025. Lucyd, Inc was founded in 2019 and is headquartered in North Miami, Florida.

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Aug 15, 2022

Website

LUCY Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Jun 26	Mar 26	Sep 25	Jun 25	Mar 25
Subscriptions	$3.21K	$1.80K	$325.00	$908.00	$1.03K

Fiscal year ends in Dec 25 | Currency in USD

LUCY Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$2.66B	$1.64M	$1.15M
Operating Income	$-2.41B	$-7.92M	$-6.86M
Net Income	$-7.59B	$-7.77M	$-6.66M
EBITDA	$-2.41B	$-7.62M	$-6.58M
Basic EPS	-	$-5.19	$-12.67
Diluted EPS	-	$-5.19	$-12.67

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
POAI	Predictive Oncology Inc.
PFSA	Profusa, Inc. Common Stock
CELZ	Creative Medical Technology Holdings, Inc.
SBFM	Sunshine Biopharma, Inc.
MHUA	Meihua International Medical Technologies Co., Ltd.
BMRA	Biomerica, Inc.
KPRX	Kiora Pharmaceuticals, Inc.
APRE	Aprea Therapeutics, Inc.
BCDA	BioCardia, Inc.